Carregant...
Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression
We identified SMYD2, a SMYD (SET and MYND domain) family protein with lysine methyltransferase activity, as a novel breast cancer oncogene. SMYD2 was expressed at significantly higher levels in breast cancer cell lines and in breast tumor tissues. Silencing of SMYD2 by RNAi in triple-negative breast...
Guardat en:
| Publicat a: | Cell Death Dis |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5832424/ https://ncbi.nlm.nih.gov/pubmed/29487338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-018-0347-x |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|